In this review:
This publication will present and discuss the findings of the PALMFlexS study of the long-acting injectable antipsychotic paliperidone palmitate in patients with clinically stable but symptomatic (nonacute) schizophrenia who were switched from oral antipsychotic agents.
Download PDF